PAIOF (Paion AG) Total Inventories: $4.64 Mil (As of Jun. 2023)


PAIOF Paion AG PAIOF
10 GF Score
Price $0.01
View Full Analysis

What is Paion AG Total Inventories?

Paion AG PAIOF +9,900.00% 10 Total Inventories is $4.64 Mil as of Jun. 2023. GuruFocus rates PAIOF with a GF Score™ of 10/100.

Paion AG's total inventories for the quarter that ended in Jun. 2023 was $4.64 Mil. Paion AG's average total inventories from the quarter that ended in Dec. 2022 to the quarter that ended in Jun. 2023 was $4.29 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Paion AG's Net-Net Working Capital per share for the quarter that ended in Jun. 2023 was $-4.12.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Paion AG's Days Inventory for the six months ended in Jun. 2023 was 202.30.

Inventory Turnover measures how fast the company turns over its inventory within a year. Paion AG's Inventory Turnover for the quarter that ended in Jun. 2023 was 0.90.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Paion AG's Inventory-to-Revenue for the quarter that ended in Jun. 2023 was 0.58.


Paion AG  (OTCPK:PAIOF) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Paion AG's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2023 is

Net-Net Working Capital Per Share (Q: Jun. 2023 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(5.035+0.75 * 2.009+0.5 * 4.641-38.248
-0-0)/7.134
=-4.12

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Paion AG's Days Inventory for the six months ended in Jun. 2023 is calculated as:

Days Inventory=Average Total Inventories (Q: Jun. 2023 )/Cost of Goods Sold (Q: Jun. 2023 )*Days in Period
=4.291/3.871*365 / 2
=202.30

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Paion AG's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Jun. 2023 ) / Average Total Inventories (Q: Jun. 2023 )
=3.871 / 4.291
=0.90

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Paion AG's Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Jun. 2023 ) / Revenue (Q: Jun. 2023 )
=4.291 / 7.356
=0.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Paion AG Total Inventories Related Terms


Paion AG Total Inventories Historical Data

* Premium members only.

The historical data trend for Paion AG's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Paion AG Total Inventories Chart

Paion AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Inventories
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 1.19 5.45 3.94

Paion AG Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.65 5.45 4.48 3.94 4.64
PAIOF
10GF Score
Paion AG PAIOF
Total Inventories is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Paion AG Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Frequently Asked Questions Learn more about Total Inventories →
What does a Total Inventories of $4.64 Mil mean?
Paion AG (PAIOF) has a Total Inventories of $4.64 Mil as of Jun. 2023. The total amount of inventory as recorded on a company's balance sheet. View historical data for Paion AG and its competitors.
Is Paion AG's Total Inventories too high?
Paion AG's current Total Inventories is $4.64 Mil. Overall, Paion AG has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Paion AG's Total Inventories compare to ZTS and NBIX?
Paion AG's Total Inventories of $4.64 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Drug Manufacturers company?
A good Total Inventories depends on the Drug Manufacturers industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Paion AG and its competitors. Paion AG's current Total Inventories is $4.64 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paion AG stock overvalued right now?
Paion AG (PAIOF) has a current Total Inventories of $4.64 Mil. The current Total Inventories is $4.64 Mil. Paion AG's overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Paion AG (PAIOF), the current Total Inventories is $4.64 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Paion AG Business Description

Address Heussstrasse 25, Aachen, DEU, 52078
Paion AG is a holding company engaged in providing various services to the subsidiaries. The group is focused on developing and commercializing medical innovations for procedural sedation, anesthesia, and critical care services. The key product of the company is remimazolam, which is an ultra-short-acting intravenous benzodiazepine sedative. In the human body, remimazolam is rapidly metabolized to an inactive metabolite by tissue esterases and not metabolized by cytochrome-dependent hepatic pathways. The organization is based in Germany.
10GF Score

Get the complete analysis for PAIOF

Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.01
Price